TGFB1 and Miyoshi myopathy: This repression was almost completely abrogated by using a TGFβ type I receptor inhibitor (SB431542) or an anti-pan/TGFβ mAb (Fig. 7C, D), confirming that this cytokine has a major role in the suppression of NK cell functions in the MM BM microenvironment.